200 related articles for article (PubMed ID: 31538911)
1. Mesenchymal stem cells from bone marrow regulate invasion and drug resistance of multiple myeloma cells by secreting chemokine CXCL13.
Zhang G; Miao F; Xu J; Wang R
Bosn J Basic Med Sci; 2020 May; 20(2):209-217. PubMed ID: 31538911
[TBL] [Abstract][Full Text] [Related]
2. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
Xu X; Yang J; Tang Y; Li J; Zhu Y; Lu H; Fei X
Int J Clin Exp Pathol; 2014; 7(10):6705-15. PubMed ID: 25400750
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway.
Zhao P; Chen Y; Yue Z; Yuan Y; Wang X
Leuk Res; 2017 Jun; 57():20-26. PubMed ID: 28273548
[TBL] [Abstract][Full Text] [Related]
4. [Effect of Bone Marrow Mesenchymal Stem Cells in Patients with Multiple Myelima on Migration of Myeloma Cells In Vitro].
Zhang XX; Zhang LF; Liu L; Li HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):484-488. PubMed ID: 29665920
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
Que W; Chen J; Chuang M; Jiang D
APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
[TBL] [Abstract][Full Text] [Related]
6. [The effect of TNF-alpha on TAZ expression and osteogenic potential of mesenchymal stem cells from myeloma patients].
Li BZ; Shi MX; Li J; Ma J; Chen L; Chen B; Zhao CH
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):5-9. PubMed ID: 19538860
[TBL] [Abstract][Full Text] [Related]
7. Suitable drug combination with bortezomib for multiple myeloma under stroma-free conditions and in contact with fibronectin or bone marrow stromal cells.
Kikuchi J; Koyama D; Mukai HY; Furukawa Y
Int J Hematol; 2014 Jun; 99(6):726-36. PubMed ID: 24706190
[TBL] [Abstract][Full Text] [Related]
8. Protein Kinase D 1 Predicts Poor Treatment Response and Unfavorable Survival of Bortezomib-Based Treatment, and Its Knockdown Enhances Drug Sensitivity to Bortezomib in Multiple Myeloma.
Li X; Yang Y; Yi X
Technol Cancer Res Treat; 2020; 19():1533033820936770. PubMed ID: 32799769
[TBL] [Abstract][Full Text] [Related]
9. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer effects of Staphylococcal Enterotoxin type B on U266 cells co-cultured with Mesenchymal Stem Cells.
Ejtehadifar M; Halabian R; Fooladi AAI; Ghazavi A; Mosayebi G
Microb Pathog; 2017 Dec; 113():438-444. PubMed ID: 29170042
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes multiple myeloma resistance through the JAK2/STAT3 pathway.
Huang J; Huang LQ; He HS; Yan J; Huang C; Wang R; Guan Y; Huang DP
Life Sci; 2020 Sep; 257():118088. PubMed ID: 32663573
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of BOR-Resistant U266 Cell Line and the Detection of Its Biological Activities].
Liu HL; Que WZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1722-1726. PubMed ID: 29262905
[TBL] [Abstract][Full Text] [Related]
13. SRC3 expressed in bone marrow mesenchymal stem cells promotes the development of multiple myeloma.
Jin J; Cheng S; Wang Y; Wang T; Zeng D; Li Z; Li X; Wang J
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1258-1266. PubMed ID: 31769473
[TBL] [Abstract][Full Text] [Related]
14. BAY-11-7082 induces apoptosis of multiple myeloma U266 cells through inhibiting NF-κB pathway.
Wang Y; Zhang XL; Sun CM
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2564-2571. PubMed ID: 29771406
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
[TBL] [Abstract][Full Text] [Related]
16. Survivin is upregulated in myeloma cell lines cocultured with mesenchymal stem cells.
Wang X; Zhang Z; Yao C
Leuk Res; 2010 Oct; 34(10):1325-9. PubMed ID: 20627293
[TBL] [Abstract][Full Text] [Related]
17. High glucose prevents osteogenic differentiation of mesenchymal stem cells via lncRNA AK028326/CXCL13 pathway.
Cao B; Liu N; Wang W
Biomed Pharmacother; 2016 Dec; 84():544-551. PubMed ID: 27693963
[TBL] [Abstract][Full Text] [Related]
18. NF-Kβ Activation in U266 Cells on Mesenchymal Stem Cells.
Zahedi S; Shamsasenjan K; Movassaghpour A; Akbarzadehlaleh P
Adv Pharm Bull; 2016 Sep; 6(3):415-422. PubMed ID: 27766226
[No Abstract] [Full Text] [Related]
19. Mesenchymal stem cells derived from multiple myeloma patients protect against chemotherapy through autophagy-dependent activation of NF-κB signaling.
Yang H; Zheng Y; Zhang Y; Cao Z; Jiang Y
Leuk Res; 2017 Sep; 60():82-88. PubMed ID: 28759800
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib promotes apoptosis of multiple myeloma cells by regulating HSP27.
Li J; Zhang X; Shen J; Guo J; Wang X; Liu J
Mol Med Rep; 2019 Sep; 20(3):2410-2418. PubMed ID: 31322176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
